These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14697812)

  • 21. Equity in access to ARV drugs in Malawi.
    Ntata PR
    SAHARA J; 2007 May; 4(1):564-74. PubMed ID: 18040535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commentary: scaling up HIV treatment in resource-limited countries: the challenge of staff shortages.
    Laurent C
    J Public Health Policy; 2011 May; 32(2):211-8. PubMed ID: 21346787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO's 3-by-5 target.
    Taylor K; DeYoung P
    Lancet; 2003 Sep; 362(9387):918. PubMed ID: 13678988
    [No Abstract]   [Full Text] [Related]  

  • 24. WHO's HIV/AIDS strategy under the spotlight.
    Kim JY
    Bull World Health Organ; 2004 Jun; 82(6):474-6. PubMed ID: 15356946
    [No Abstract]   [Full Text] [Related]  

  • 25. Contributions of national and global health estimates to monitoring health-related Sustainable Development Goals in Thailand.
    Bundhamcharoen K; Limwattananon S; Kusreesakul K; Tangcharoensathien V
    Glob Health Action; 2017; 10(sup1):1266175. PubMed ID: 28532308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The World Health Report 2000: World Health Organization health policy steering off course-changed values, poor evidence, and lack of accountability.
    Ollila E; Koivusalo M
    Int J Health Serv; 2002; 32(3):503-14. PubMed ID: 12211290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
    Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
    Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A report on the Zimbabwe Antiretroviral Therapy (ART) programme progress towards achieving MGD6 target 6B: achievement and challenges.
    Apollo T; Takarinda K; Mugurungi O; Chakanyuka C; Simbini T; Harries AD
    Cent Afr J Med; 2010; 56(1-4):12-4. PubMed ID: 23457867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the failure of 3 by 5.
    Harries AD
    Lancet; 2005 Jul 9-15; 366(9480):117. PubMed ID: 16005322
    [No Abstract]   [Full Text] [Related]  

  • 31. Shaping the future depends on strengthening health systems.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):337-8. PubMed ID: 15119343
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS governance: best practices for a post-2015 world.
    Sidibé M; Buse K
    Lancet; 2013 Jun; 381(9884):2147-9. PubMed ID: 23791333
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from Harlem: Relevance to a global epidemic.
    Abrams EJ; El-Sadr WM
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S24-6. PubMed ID: 19858932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress in health-related millennium development goals in the WHO South-East Asia Region.
    Singh PK
    Indian J Public Health; 2012; 56(4):259-68. PubMed ID: 23354135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis and HIV-infection in developing countries.
    Broekmans JF
    Trop Geogr Med; 1991 Jul; 43(3):S13-21. PubMed ID: 1687768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "3 by 5" should be replaced by "Free by 5".
    Bosch X
    Lancet Infect Dis; 2005 Feb; 5(2):76. PubMed ID: 15702506
    [No Abstract]   [Full Text] [Related]  

  • 38. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mexico, 2004: research for global health and security.
    Lancet; 2003 Dec; 362(9401):2033. PubMed ID: 14697796
    [No Abstract]   [Full Text] [Related]  

  • 40. Using the power of the World Health Organization: the international health regulations and the future of international health law.
    Forrest M
    Spec Law Dig Health Care Law; 2001 Sep; (269):9-35. PubMed ID: 11588888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.